Clinical outcome of confluent laser photoablation for retinopathy of prematurity

Journal of AAPOS

Volumn 6, Issue 2, 2002, Pages 81-85

  Fallaha, Nicole ^a   Lynn, Michael T ^b   Aaberg Jr , Thomas M ^a   Lambert, Scott R ^a  

^a EMORY EYE CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CATARACT; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA EDEMA; CRYOTHERAPY; DISEASE COURSE; ECTOPIC TISSUE; FEMALE; HUMAN; ISCHEMIA; LOW LEVEL LASER THERAPY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REFRACTION ERROR; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; TECHNIQUE; VITREOUS HEMORRHAGE; BIRTH WEIGHT; EVALUATION; GESTATIONAL AGE; LASER COAGULATION; NEWBORN; PATHOPHYSIOLOGY; REOPERATION; TREATMENT OUTCOME;

BIRTH WEIGHT; DISEASE PROGRESSION; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LASER COAGULATION; MALE; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036546483     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpa.2002.121452     Document Type: Article

References (34)

1. Termote J, Schalij-Delfos NE, Brouwers H AA, Donders ART, Cats BP. New developments in neonatology: less severe retinopathy of prematurity? J Pediatr Ophthalmol Strabismus 2000;37:142-8.
2. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics 1999;104:e26 [Electronic article.].
3. Cryotherapy for retinopathy of prematurity cooperative group. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol 1988;106:471-9.
4. Cryotherapy for retinopathy of prematurity cooperative group. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function. Arch Ophthalmol 1990;108:1408-16.
5. Cryotherapy for retinopathy of prematurity cooperative group. Multicenter trial of cryotherapy for retinopathy of prematurity. 32-year outcome-structure and function. Arch Ophthalmol 1993;111:339-44.
6. Cryotherapy for retinopathy of prematurity cooperative group. Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen's visual acuity and structural outcome at 52 years after randomization. Arch Ophthalmol 1996;114:417-24.
7. Vander JF, Handa J, McNamara A, Trese M, Spencer R, Repka MX, et al. Early treatment of posterior retinopathy of prematurity. A controlled trial. Ophthalmology 1997;104:1731-6.
8. Fleming TN, Runge PE, Charles ST. Diode laser photocoagulation for prethreshold, posterior retinopathy of prematurity. Am J Ophthalmol 1992;114:589-92.
9. Onofrey CB, Feuer Wf, Flynn JT. The outcome of retinopathy of prematurity. Screening for retinopathy of prematurity using an outcome predictive program. Ophthalmology 2001;108:27-35.
10. Paysse EA, Lindsey JL, Coats DK, Contant CF, Steinkuller PG. Therapeutic outcomes of cryotherapy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity. J AAPOS 1999;3:234-40.
11. Connolly BP, McNamara A, Regillo CD, Tasman W, Sharma S. Visual outcomes after laser photocoagulation for threshold retinopathy of prematurity. Ophthalmology 1999;106:1734-8.
12. Connolly BP, McNamara A, Sharma S, Regillo CD, Tasman W. A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity. Ophthalmology 1998;105:1628-31.
13. Dejonge MH, Ferrone PJ, Trese MT. Diode laser ablation for threshold retinopathy of prematurity. Short-term structural outcome. Arch Ophthalmol 2000;118:365-7.
14. Gonzalez I, Ferrer C, Pueyo M, Melcon B, Ferrer E, Honrubia FM. Diode laser photocoagulation in retinopathy of prematurity. Eur J Ophthalmol 1997;7:55-8.
15. Seiberth V, Linderkamp O, Vardarli I, Knorz MC, Liesenhoff H. Diode laser photocoagulation for stage 3+ retinopathy of prematurity. Graefe's Arch Clin Exp Ophthalmol 1995;233:489-93.
16. Ling CS, Fleck BW, Wright E, Anderson C, Laing I. Diode laser treatment for retinopathy of prematurity: structural and functional outcome. Br J Ophthalmol 1995;79:637-41.
17. Hunter DG, Repka MX. Diode laser photocoagulation for threshold retinopathy of prematurity. Ophthalmology 1993;100:238-44.
18. Laws F, Laws D, Clark D. Cryotherapy and laser treatment for acute retinopathy of prematurity: refractive outcomes, a longitudinal study. Br J Ophthalmol 1997;81:12-5.
19. Knight-Nanan DM, O'Keefe M. Refractive outcome in eyes with retinopathy of prematurity treated with cryotherapy or diode laser: 3-year follow-up. Br J Ophthalmol 1996;80:998-1001.
20. Algawi K, Goggin M, O'Keefe M. Refractive outcome following diode laser versus cryotherapy for eyes with retinopathy of prematurity. Br J Ophthalmol 1994;78:612-14.
21. Hammer ME, Pusateri TJ, Hess JB, Sosa R, Stromquist C. Threshold retinopathy of prematurity. Transition from cryotherapy to laser treatment. Retina 1995;15:486-9.
22. Christiansen SP, Bradford JD. Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity. Am J Ophthalmol 1995;119:175-80.
23. Gold RS. Cataracts associated with treatment for retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 19974;34:123-4.
24. Noonan CP, Clark DI. Acute serous detachment with argon laser photocoagulation in retinopathy of prematurity. J AAPOS 1997;1: 183-4.
25. McNamara JA. Laser treatment for retinopathy of prematurity. Curr Opin Ophthalmol 1993;4:76-80.
26. Banach MJ, Ferrone PJ, Trese MT. A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy for prematurity. Ophthalmology 2000;107:324-8.
27. Lambert SR, Capone A, Jr, Cingle KA, Drack A. Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity. Am J Ophthalmol 2000;129:585-91.
28. Capone A, Jr, Diaz-Rohena R, Sternberg P, Mandell B, Lambert HM, Lopez PF. Diode-laser photocoagulation for zone 1 threshold retinopathy of prematurity. Am J Ophthalmol 1993;116:444-50.
29. Goggin M, O'Keefe M. Diode laser for retinopathy of prematurity-early outcome. Br J Ophthalmol 1993;77:559-62.
30. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, et al. Activation of vascular endothelial growth factor gene transcription by hyperoxia-inducible factor 1. Mol Cell Biol 1996;16:4604-13.
31. Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci 1996;37:290-9.
32. Young TL, Smith LEH, Foley E, Pierce E, Anthony DC. Histopathological results and vascular endothelial growth factor mRNA expression in the retina of an infant with asymmetric retinopathy of prematurity. Invest Ophthalmol Vis Sci 1995;36(Suppl):S67.
33. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995;1:1024-8.
34. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodeling is defined by pericyte cover of the preformed endothelial network and is regulated by PDGF-B and VEG. Development 1998;125:1591-8.